MSB 0.82% 90.8¢ mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-109

  1. 1,906 Posts.
    lightbulb Created with Sketch. 491
    Again. 100% reasonable to question why exactly certain posters are continuously arbitrarily negative.

    Especially when:

    • Their excuses change with the news. Suddenly they're not harping on "from what I've read" about potency assays.
    • They play ignorant to Fast Track designation timeline
    • They are suddenly concerned about site inspection, failing to comment on the mock site inspection that was had
    • They force negative connotations on the BLA acceptance process and timelines we've had so far.
    • What ever this nonsense is "No comment on whether the BLA was filed immediately MSB resubmitted it or whether any clarifications were sought that extended the SOPP guideance time."
    • They regularly claim to be Drs themselves and throw shade at the world leading experts in the field.

    Your perception is 100% skewed towards the negative and it's clear investors are not going to be informed as why.

    In the meantime I think it's reasonable for any holder to call out the regular contradictions, hypocrisy and obtuse nature of certain posts and posters with obscure motivations.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
90.8¢
Change
-0.008(0.82%)
Mkt cap ! $1.021B
Open High Low Value Volume
90.5¢ 91.3¢ 89.5¢ $1.870M 2.079M

Buyers (Bids)

No. Vol. Price($)
18 103497 90.5¢
 

Sellers (Offers)

Price($) Vol. No.
91.0¢ 26339 26
View Market Depth
Last trade - 12.53pm 08/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.